• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc.

    1/21/25 7:22:52 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary
    Get the next $MRM alert in real time by email

    TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare technologies Inc. (NASDAQ:MRM) ("MEDIROM"), a health technology and holistic healthcare company headquartered in Tokyo, Japan and led by CEO Kouji Eguchi, is pleased to announce that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs") is now providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet®︎, to the Electronics Division of TOPPAN Inc. (Tokyo Stock Exchange: 7911).

    In recent years, employee health management has shifted from being an individual's responsibility to becoming one of the key priorities for companies. Since their founding, TOPPAN has consistently undertaken various initiatives to ensure the physical and mental well-being of their employees based on the core philosophy of respect for human beings. As part of TOPPAN's efforts to promote employee health, creating a safe and secure living environment for employees living alone, such as those on solo assignments, has been one of the key initiatives. By utilizing REMONY, TOPPAN aims to establish an environment that enables early detection and prompt responses in the event of certain health abnormalities.

    About the MOTHER Bracelet, Recharge-Free Smart Tracker

    image1.jpg

    MOTHER Bracelet is the world's first 24/7 recharge-free smart tracker, powered by advanced technology that generates electricity from the temperature difference between the body and the surrounding air. As it doesn't require recharging, it eliminates the data loss that can occur when a device is taken off for recharging. This single device can record five fundamental health metrics: heart rate, surface body temperature, step count, sleep, and calories burned. https://mother-bracelet.com

    About Remote Health Monitoring System - REMONY

    image2.png

    "REMONY" remote health monitoring system, developed by MEDIROM MOTHER Labs, combines the wrist-worn recharge-free smart tracker MOTHER Bracelet with a dedicated gateway. The system enables automatic data synchronization and centralized real-time management. Health monitoring with conventional wearables often faces challenges due to data loss during device recharge period. However, MOTHER Bracelet measures user vital data in real-time 24/7 without needing removal for recharge. As a result, it allows prompt and early detection of health emergencies and accident prevention with high accuracy. The system is customizable for use in various industries, including elderly care, health monitoring for night shift workers, etc.

    About MEDIROM Healthcare Technologies Inc.

    MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called "Lav®", which is developed by MEDIROM. MEDIROM also entered the device business in 2020 and has developed a smart tracker "MOTHER Bracelet®". In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en

    Contact:

    Investor Relations Team

    E-mail: [email protected]

    About TOPPAN Inc.

    image4.png

    TOPPAN Inc. develops solutions based on its printing technologies in Japan and internationally. It operates through three business segments: Information & Communication, Living & Industry, and Electronics. Its Information & Communication business offers securities, passbooks, cards, business forms, catalogs, and printed advertising media, as well as printed publication media, such as magazines and books, and business process outsourcing. The Living & Industry business provides packaging, including flexible packaging materials and folding cartons, rigid plastic products, inks, and transparent barrier films; and decor materials, such as decorative sheets and wallpapers. Its Electronics business offers LCD color filters, TFT-LCDs, antireflection films, photomasks, and semiconductor package products. TOPPAN Inc. is the core operating company of the TOPPAN Group, which was reorganized into a holding company structure in October 2023, 123 years after Toppan Printing was founded in Tokyo in 1900. https://www.toppan.com/en/

    Forward-Looking Statements Regarding MEDIROM

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM's operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

    • MEDIROM's ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
    • changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM's expansion in Japan and certain overseas markets;
    • MEDIROM's ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
    • the fluctuation of foreign exchange rates, which affects MEDIROM's expenses and liabilities payable in foreign currencies;
    • MEDIROM's ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
    • MEDIROM's ability to raise additional capital on acceptable terms or at all;
    • MEDIROM's level of indebtedness and potential restrictions on MEDIROM under MEDIROM's debt instruments;
    • changes in consumer preferences and MEDIROM's competitive environment;
    • MEDIROM's ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
    • the regulatory environment in which MEDIROM operates.

    More information on these risks and other potential factors that could affect MEDIROM's business, reputation, results of operations, financial condition, and stock price is included in MEDIROM's filings with the Securities and Exchange Commission (the "SEC"), including in the "Risk Factors" and "Operating and Financial Review and Prospects" sections of MEDIROM's most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

    A photo accompanying this announcement is available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/eb4bfdb8-465d-4f87-ba73-858fbc72229f

    https://www.globenewswire.com/NewsRoom/AttachmentNg/c6a270c0-1d07-440c-8231-b2d8edfc2508

    https://www.globenewswire.com/NewsRoom/AttachmentNg/1e0a44c0-8515-4775-ad06-af40145d4cc2



    Primary Logo

    Get the next $MRM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MRM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MRM
    Financials

    Live finance-specific insights

    See more
    • MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.

      TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to

      10/7/24 4:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023

      TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel

      6/25/24 9:37:44 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results

      NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o

      5/13/22 7:53:59 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

      SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      12/10/24 7:38:12 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/25/23 4:16:06 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/6/23 6:12:19 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Leadership Updates

    Live Leadership Updates

    See more
    • "NASDAQ JAPAN IR EVENT" to Be Held at Nasdaq MarketSite on June 20, 2024

      NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor

      5/20/24 3:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET

      TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See "Convenience Translations to US Dollars" below for more information.) Net income for 2024 was $878,000, or $0.17 per basic share,

      5/20/25 8:56:16 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

      TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM") today announced that it will host a webcast to review the Company's financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company's financial results for the 2024 fiscal year and is available on the Securities and Exchange Comm

      5/19/25 8:44:53 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing

      TOKYO, March 17, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that it has obtained a new unsecured short-term bank loan in the amount of JPY350 million (approximately $2.4 million*). The Company has used JPY200 million of the loan funds for repayment of indebtedness of MEDIROM Mother Labs Inc., a subsidiary of the Company which is also a guarantor of the new loan, and the Company intends to use the remainder of the loan funds for general working capital, including Mother Bracelet development. The loan bears interest at a rate of 1.875% per year. "This new loan fina

      3/17/25 5:30:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    SEC Filings

    See more
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 8:00:20 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 6:10:32 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 20-F filed by MEDIROM Healthcare Technologies Inc.

      20-F - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      4/29/25 4:15:44 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary